135 related articles for article (PubMed ID: 21052922)
1. Depolarizing focal macular electroretinogram pattern after photodynamic therapy in a patient with polypoidal choroidal vasculopathy.
Nishimura T; Machida S; Tamada K; Kurosaka D
Jpn J Ophthalmol; 2010 Sep; 54(5):509-11. PubMed ID: 21052922
[No Abstract] [Full Text] [Related]
2. Reduced-fluence photodynamic therapy for polypoidal choroidal vasculopathy.
Chhablani J
Am J Ophthalmol; 2010 Sep; 150(3):443-4; author reply 444. PubMed ID: 20728684
[No Abstract] [Full Text] [Related]
3. Photodynamic therapy for polypoidal choroidal vasculopathy.
Kumar Chhablani J
Graefes Arch Clin Exp Ophthalmol; 2011 May; 249(5):791; author reply 793. PubMed ID: 20689963
[No Abstract] [Full Text] [Related]
4. Clinical features and follow-up results of pulsating polypoidal choroidal vasculopathy treated with photodynamic therapy.
Byeon SH; Lew YJ; Lee SC; Kwon OW
Acta Ophthalmol; 2010 Sep; 88(6):660-8. PubMed ID: 19563374
[TBL] [Abstract][Full Text] [Related]
5. Indocyanine green angiography: guided photodynamic therapy for polypoidal choroidal vasculopathy.
Otani A; Sasahara M; Yodoi Y; Aikawa H; Tamura H; Tsujikawa A; Yoshimura N
Am J Ophthalmol; 2007 Jul; 144(1):7-14. PubMed ID: 17467649
[TBL] [Abstract][Full Text] [Related]
6. Correlation of indocyanine green angiography and optical coherence tomography findings after intravitreal ranibizumab for polypoidal choroidal vasculopathy.
Ueno C; Gomi F; Sawa M; Nishida K
Retina; 2012; 32(10):2006-13. PubMed ID: 22772392
[TBL] [Abstract][Full Text] [Related]
7. Short-term focal macular electroretinogram of eyes treated by aflibercept & photodynamic therapy for polypoidal choroidal vasculopathy.
Takayama K; Kaneko H; Kataoka K; Ueno S; Chang-Hua P; Ito Y; Terasaki H
Graefes Arch Clin Exp Ophthalmol; 2017 Mar; 255(3):449-455. PubMed ID: 27538907
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of intravitreal bevacizumab combined with photodynamic therapy for polypoidal choroidal vasculopathy.
Gomi F; Sawa M; Wakabayashi T; Sasamoto Y; Suzuki M; Tsujikawa M
Am J Ophthalmol; 2010 Jul; 150(1):48-54.e1. PubMed ID: 20609707
[TBL] [Abstract][Full Text] [Related]
9. Central retinal sensitivity measured with the micro perimeter 1 after photodynamic therapy for polypoidal choroidal vasculopathy.
Yodoi Y; Tsujikawa A; Kameda T; Otani A; Tamura H; Mandai M; Yoshimura N
Am J Ophthalmol; 2007 Jun; 143(6):984-994. PubMed ID: 17336913
[TBL] [Abstract][Full Text] [Related]
10. Polypoidal choroidal vasculopathy and macroaneurysm: respective roles of scanning laser ophthalmoscopy-indocyanine green angiography and optical coherence tomography.
Coscas F; Coscas G; Souïed E
Eur J Ophthalmol; 2011; 21(3):331-5. PubMed ID: 20853255
[TBL] [Abstract][Full Text] [Related]
11. Photodynamic therapy with verteporfin in polypoidal choroidal vasculopathy: results after 3 years of follow-up.
Leal S; Silva R; Figueira J; Cachulo ML; Pires I; de Abreu JR; Cunha-Vaz JG
Retina; 2010 Sep; 30(8):1197-205. PubMed ID: 20827139
[TBL] [Abstract][Full Text] [Related]
12. Hyalinization of choroidal vessels in polypoidal choroidal vasculopathy.
Nakashizuka H; Yuzawa M
Surv Ophthalmol; 2011; 56(3):278-9; author reply 279. PubMed ID: 21501743
[No Abstract] [Full Text] [Related]
13. Intravitreal ranibizumab combined with verteporfin photodynamic therapy for treating polypoidal choroidal vasculopathy.
Lee YH; Lee EK; Shin KS; Lee KM; Kim JY
Retina; 2011; 31(7):1287-93. PubMed ID: 21386762
[TBL] [Abstract][Full Text] [Related]
14. Intravitreal ranibizumab for polypoidal choroidal vasculopathy with recurrent or residual exudation.
Saito M; Iida T; Kano M
Retina; 2011 Sep; 31(8):1589-97. PubMed ID: 21654347
[TBL] [Abstract][Full Text] [Related]
15. Photodynamic therapy for polypoidal choroidal vasculopathy.
Chhablani JK
Am J Ophthalmol; 2010 Nov; 150(5):754-5; author reply 755. PubMed ID: 21036213
[No Abstract] [Full Text] [Related]
16. Nasal and independent polypoidal lesions in polypoidal choroidal vasculopathy.
Okubo A; Abematsu N; Sakamoto T
Graefes Arch Clin Exp Ophthalmol; 2009 Mar; 247(3):421-5. PubMed ID: 18850106
[TBL] [Abstract][Full Text] [Related]
17. Intravitreal ranibizumab with or without photodynamic therapy for the treatment of symptomatic polypoidal choroidal vasculopathy.
Lai TY; Lee GK; Luk FO; Lam DS
Retina; 2011 Sep; 31(8):1581-8. PubMed ID: 21610566
[TBL] [Abstract][Full Text] [Related]
18. Macular complications on the border of an inferior staphyloma associated with tilted disc syndrome.
Nakanishi H; Tsujikawa A; Gotoh N; Hayashi H; Iwama D; Tamura H; Otani A; Yoshimura N
Retina; 2008; 28(10):1493-501. PubMed ID: 18667957
[TBL] [Abstract][Full Text] [Related]
19. Two-year results of reduced-fluence photodynamic therapy for polypoidal choroidal vasculopathy.
Yamashita A; Shiraga F; Shiragami C; Shirakata Y; Fujiwara A
Am J Ophthalmol; 2013 Jan; 155(1):96-102.e1. PubMed ID: 22995028
[TBL] [Abstract][Full Text] [Related]
20. One-year outcomes of intravitreal bevacizumab (avastin) therapy for polypoidal choroidal vasculopathy.
Cheng CK; Peng CH; Chang CK; Hu CC; Chen LJ
Retina; 2011 May; 31(5):846-56. PubMed ID: 21317837
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]